Skip to main content
. 2023 Dec 11;47(Suppl 1):S219–S230. doi: 10.2337/dc24-S011

Table 11.1.

Screening for selected complications of chronic kidney disease

Complication Physical and laboratory evaluation
Blood pressure >130/80 mmHg Blood pressure, weight, BMI
Volume overload History, physical examination, weight
Electrolyte abnormalities Serum electrolytes
Metabolic acidosis Serum electrolytes
Anemia Hemoglobin; iron, iron saturation, ferritin testing if indicated
Metabolic bone disease Serum calcium, phosphate, PTH, vitamin 25(OH)D

Complications of chronic kidney disease (CKD) generally become prevalent when estimated glomerular filtration rate falls below 60 mL/min/1.73 m2 (stage G3 CKD or greater) and become more common and severe as CKD progresses. Evaluation of elevated blood pressure and volume overload should occur at every clinical contact possible; laboratory evaluations are generally indicated every 6–12 months for stage G3 CKD, every 3–5 months for stage G4 CKD, and every 1–3 months for stage G5 CKD, or as indicated to evaluate symptoms or changes in therapy. PTH, parathyroid hormone; 25(OH)D, 25-hydroxyvitamin D.